Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)
3301 Agriculture Drive
Madison
Wisconsin
53716
United States
Tel: 608-441-8120
Fax: 608-441-8120
Website: http://cellectar.com/
256 articles about Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)
-
Novelos Therapeutics, Inc. Receives Notice of Allowance For 5th U.S. Patent; Further Strengthening Novelos' Commanding IP
9/11/2006
-
The Day In Review: Immunicon Corporation Rises On AstraZeneca PLC Deal
8/7/2006
-
Novelos Therapeutics, Inc. Obtains FDA Fast Track Designation For NOV-002 Lung Cancer Treatment
8/7/2006
-
Novelos Therapeutics, Inc. Announces Enrollment Of 1st Patient In Phase 2 Ovarian Cancer Trial At Dana-Farber/Partners Cancer Care
7/18/2006
-
Novelos Therapeutics, Inc. ''Dirty Bomb'' Treatment Proposal Approved By U.S. Government For Round 2 Evaluation
6/26/2006
-
Novelos Therapeutics, Inc. Finalizes SPA With FDA For Phase 3 Trial In Lung Cancer
5/30/2006
-
Novelos Therapeutics, Inc. To Present At Rodman & Renshaw 3rd Annual Global Healthcare Conference
5/8/2006
-
Novelos Therapeutics, Inc. IND For Novel Hepatitis C Drug Is Accepted By FDA
4/24/2006
-
Novelos Therapeutics, Inc. Files IND For Novel Hepatitis C Drug; IND Represents Company's Second Clinical Stage Compound
3/22/2006
-
Novelos Therapeutics, Inc. Files SPA With FDA For Phase 3 Development In Lung Cancer
3/8/2006
-
Novelos Therapeutics, Inc. Closes $15 Million Private Placement
3/8/2006
-
Novelos Therapeutics, Inc. Announces $15 Million Private Placement, Supplementing Today's Earlier Announcement
3/3/2006
-
Novelos Therapeutics, Inc. Announces $12.9 Million Private Placement
3/2/2006
-
Novelos Therapeutics, Inc. Gets Green Light From FDA For Phase 3 Development In Lung Cancer
12/5/2005
-
Novelos Therapeutics, Inc. To Meet FDA In Early December To Review Positive Phase 1/2 Lung Cancer Data
10/24/2005
-
WILink Release: 20 Companies To Present At Biotechnology / Healthcare / Pharmaceuticals Forum In NYC On June 15
5/26/2005